LifeStance Health (LFST) Short-term Investments (2022 - 2025)

LifeStance Health has disclosed Short-term Investments across 4 years of filings, most recently posting $489000.0 for Q2 2025.

• In Q2 2025, Short-term Investments fell 86.36% year-over-year to $489000.0; the TTM figure through Jun 2025 stood at $489000.0 (down 86.36% YoY), while the FY2024 annual figure was $1.3 million, down 56.6% from the prior year.
• Short-term Investments eased to $489000.0 in Q2 2025, from $847000.0 in the prior quarter.
• Over the last five years, Short-term Investments for LFST reached as high as $62.6 million in Q2 2023 and fell as low as $489000.0 in Q2 2025.
• The 4-year median for Short-term Investments is $3.6 million (2024), against an average of $13.1 million.
• Annual changes were most pronounced in 2023 — Short-term Investments tumbled 33.78% — and 2024, when it tumbled 94.28%.
• A 4-year view of Short-term Investments shows it stood at $4.4 million in 2022, then plunged by 33.78% to $2.9 million in 2023, then sank by 56.6% to $1.3 million in 2024, then sank by 61.56% to $489000.0 in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $489000.0, $847000.0, and $1.3 million for Q2 2025, Q1 2025, and Q4 2024 respectively.